30 closest matches · ranked by relevance
Stability & Variability of Lipid-derived Molecules in Sweat
Primary: Volar Forearm Sweat Lipid Mediator Concentrations Following Pilocarpine Stimulation — 20; 46; 2.2; 3.5 picomoles per milliliter
Dehydration
Primary: Number of Measurements Grouped by Level or Error — 48; 48; 49; 50 Number of measurements
Lower Extremity Amputation
Primary: Adherence — 1; 8; 3 millimeters — p=.037
Electrolyte Imbalance · Hyponatremia · Hypernatremia
Primary: Sweat Sodium Concentration Obtained After the Steady-state Portion of the Trial — 80.1; 76.8; 84.7 mEq/L
Dry Eye Syndromes
Primary: Change in Tear Lipid Layer Thickness — 4.8; 8.8 nm
Hyperthermia · Cocaine Use · Exercise
Primary: Change in Core Temperature — 1.19; 1.09; 1.20; 0.89 Celsius
Blepharitis
Primary: Global Response to Therapy — 16; 41 eyes — p=.001
Healthy
Primary: Normalized LL-37 Expression — 100 percentage of baseline
Acute Exercise · Heat Exposure
Primary: Skin Blood Flow — 188.4; 139.2 arbitrary units — p=0.284
Amputation Stumps · Amputees · Amputation
Primary: Residual Limb Temperature — 3.0; 3.2 Degrees Fahrenheit
Healthy
Primary: Impact of Ingredients on Thickness (Depth, nm) of Salivary Films Adsorbed Onto Solid Surfaces — 27 nm
Dry Eye Syndrome · Lipid Deficiency
Primary: Mean Bulbar Conjunctival Staining — 0.743; 0.442; 0.531; 0.443 percentage of staining
Acute Exercise · Heat Exposure
Primary: Skin Blood Flow — 131.6; 119.2 arbitrary units — p=0.742
Xerosis Cutis
Primary: Transepidermal Water Loss (TEWL) in g/m2/h at the Left Mid Volar Forearm — 10.0; 11.9 g/m2/h — p=0.002
Stoma Ileostomy
Primary: Resistance (Moisture in the Adhesive) — 0; 0 Number of false positive leaks
Hyperhidrosis
Primary: Comparison of Mean Average (Standard Deviation) Total Palmar Gravimetric Sweat Production (GMSP) Between Subject Groups (Adult Patients With Hyperhidrosis Versus Healthy…
Lipid Metabolism Disorders
Primary: Cholesterol Efflux Capacity (CEC) — 1.30; 0.65 Ratio
Nicotine E-Cigarette Use
Primary: Irritation/Harshness — 1.04; 1.07; 1.03; 1.01 units on a scale — p=0.0014
Dry Eye
Primary: Tear Lipid Layer Thickness — 0.72; -7.58; 2.06; 1.41 nm
Obesity
Primary: Oleic Acid Detection Level — -0.3; -1.2; -1.0 log10 (%W/V OLEIC ACID) — p=0.05
Cystic Fibrosis
Primary: Change in Average Mucociliary Clearance (0-90 Minutes) at 1 and 4 Hrs Post Dose (MCC4hr - MCCbaseline; MCC1hr - MCCbaseline) — 5.9; 6.7 Absolute % change
Skin Hydration in Healthy Volunteers
Primary: Duration — 36.71; 36.31; 7.95; 20.98 arbitrary units
Endothelial Dysfunction
Primary: Endothelial Glycocalyx Thickness — 2.28 micrometer
Healthy Skin
Primary: Relative 16S Abundance - Control Soap — 100; 74; 84; 100 Percentage of Baseline
Obesity Adult Onset
Primary: Mean Pro-inflammatory & Pro-resolving Metabolites — 15.6; 12.2; 6.6; 8.1 ng/mL
Cystic Fibrosis · Healthy
Primary: Exhaled Sodium (mmol/L) — 2.58; 2.24; 1.97; 2.11 mmol/L
Primary Axillary Hyperhidrosis
Primary: Safety of the N-SWEAT Patch — 14; 4 Participants
Sunscreening Agents
Primary: Arithmetic Mean of Individual Sun Protection Factor (SPFi) Values — 17.3; 17.9; 19.3; 18.4 Ratio
Diabetes Mellitus, Type 2 · Pre-diabetes · Obesity
Primary: Percent Change in Insulin Sensitivity Compared to Baseline Measurement. — 31.8; 17.4; -4.8 Percent change
Contact Lens Solutions
Primary: Objective, In-vivo Soft Contact Lens Wettability Index — -1.82; -1.98 wettability index